| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |